Cargando…
Protein biosynthesis, a target of sorafenib, interferes with the unfolded protein response (UPR) and ferroptosis in hepatocellular carcinoma cells
Sorafenib is the first line treatment for advanced hepatocellular carcinoma (HCC). We explored its impact on the proteostasis of cancer cells, i.e. the processes that regulate the synthesis, maturation and turn-over of cellular proteins. We observed that sorafenib inhibits the production of the tumo...
Autores principales: | Sauzay, Chloé, Louandre, Christophe, Bodeau, Sandra, Anglade, Frédéric, Godin, Corinne, Saidak, Zuzana, Fontaine, Jean-Xavier, Usureau, Cédric, Martin, Nathalie, Molinie, Roland, Pascal, Julie, Mesnard, François, Pluquet, Olivier, Galmiche, Antoine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823558/ https://www.ncbi.nlm.nih.gov/pubmed/29492203 http://dx.doi.org/10.18632/oncotarget.23843 |
Ejemplares similares
-
Metallothionein-1 as a biomarker of altered redox metabolism in hepatocellular carcinoma cells exposed to sorafenib
por: Houessinon, Aline, et al.
Publicado: (2016) -
Impact and Relevance of the Unfolded Protein Response in HNSCC
por: Pluquet, Olivier, et al.
Publicado: (2019) -
DNA damage response- and JAK-dependent regulation of PD-L1 expression in head and neck squamous cell carcinoma (HNSCC) cells exposed to 5-fluorouracil (5-FU)
por: Lailler, Claire, et al.
Publicado: (2021) -
The Tumor Coagulome as a Transcriptional Target and a Potential Effector of Glucocorticoids in Human Cancers
por: Racine, Floriane, et al.
Publicado: (2023) -
A pan-cancer study of the transcriptional regulation of uricogenesis in human tumours: pathological and pharmacological correlates
por: Saidak, Zuzana, et al.
Publicado: (2018)